The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Neuropilin‐1 expression by tumor cells promotes tumor angiogenesis and progression
Abstract
Neuropilin‐1 (NRP1) is a VEGF 165 and semaphorin receptor expressed by vascular endothelial cells (EC) and tumor cells. The function of NRP1 in tumor cells is unknown. NRP1 was overexpressed in Dunning rat prostate carcinoma AT2.1 cells using a tetracycline‐inducible promoter. Concomitant with increased NRP1 expression in response to a tetracycline homologue, doxycycline (Dox), basal cell motility, and VEGF 165 binding were increased three‐ to fourfold in vitro. However, induction of NRP1 did not affect tumor cell proliferation. When rats injected with AT2.1/NRP1 tumor cells were fed Dox, NRP1 synthesis was induced in vivo and AT2.1 cell tumor size was increased 2.5‐ to 7‐fold in a 3–4 wk period compared to controls. The larger tumors with induced NRP1 expression were characterized by markedly increased microvessel density, increased proliferating EC, dilated blood vessels, and notably less tumor cell apoptosis compared to noninduced controls. It was concluded that NRP1 expression results in enlarged tumors associated with substantially enhanced tumor angiogenesis.—Miao, H.‐Q., Lee, P., Lin, H., Soker, S., Klagsbrun, M. Neuropilin‐1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J. 14, 2532–2539 (2000)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Vascular endothelial growth factor (VEGF) and its receptors
NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,483
The Molecular Biology of Axon Guidance
Tessier-Lavigne, M., & Goodman, C. S. (1996) · Science · doi:10.1126/science.274.5290.1123 · Cited by 3,278
Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., & Klagsbrun, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81402-6 · Cited by 2,463
Self-citationPlate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., & Williams, L. T. (1992) · Science · doi:10.1126/science.1312256 · Cited by 2,016
Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., & Heldin, C. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47116-5 · Cited by 1,656
Presta, L. G., Chen, H., O'Connor, S. J., Chisholm, V., Meng, Y. G., KRUMMEN, L. A., Winkler, M., & Ferrara, N. (1997) · PubMed · Cited by 1,608
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., & Böhlen, P. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90483-2 · Cited by 1,519
Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V. W., Fang, G. H., Dumont, D., Breitman, M., & Alitalo, K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3566 · Cited by 1,423
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
Millauer, B., Shawver, L. K., Plate, K. H., Risaui, W., & Ullrich, A. (1994) · Nature · doi:10.1038/367576a0 · Cited by 1,221
Neuropilin Is a Semaphorin III Receptor
Kolodkin, A. L., Levengood, D. V., Rowe, E. G., Tai, Y.-T., Giger, R. J., & Ginty, D. D. (1997) · Cell · doi:10.1016/s0092-8674(00)80535-8 · Cited by 1,180
Collapsin: A protein in brain that induces the collapse and paralysis of neuronal growth cones
Luo, Y., Raible, D., & Raper, J. A. (1993) · Cell · doi:10.1016/0092-8674(93)80064-l · Cited by 1,179
Neuropilin Is a Receptor for the Axonal Chemorepellent Semaphorin III
He, Z., & Tessier-Lavigne, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80534-6 · Cited by 1,142
Clinical applications of angiogenic growth factors and their inhibitors
Ferrara, N., & Alitalo, K. (1999) · Nature Medicine · doi:10.1038/70928 · Cited by 1,004
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G., & Goldberg, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10595 · Cited by 892
A requirement for neuropilin-1 in embryonic vessel formation
Kawasaki, T., Kitsukawa, T., Bekku, Y., Matsuda, Y., Sanbo, M., Yagi, T., & Fujisawa, H. (1999) · Development · doi:10.1242/dev.126.21.4895 · Cited by 827
Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton
Tapon, N. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80156-1 · Cited by 814
Sondell, M., Lundborg, G., & Kanje, M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05731.1999 · Cited by 750 · cited 1×
“Schwann cells (45, 46), and bone marrow stromal”
BackgroundDvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F., & Dvorak, A. M. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59953-8_6 · Cited by 743
Kendall, R. L., Wang, G., & Thomas, K. A. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1355 · Cited by 724
Kitsukawa, T., Shimizu, M., Sanbo, M., Hirata, T., Taniguchi, M., Bekku, Y., Yagi, T., & Fujisawa, H. (1997) · Neuron · doi:10.1016/s0896-6273(00)80392-x · Cited by 656
Neuropilin-1 Mediates Collapsin-1/Semaphorin III Inhibition of Endothelial Cell Motility
Miao, H.-Q., Soker, S., Feiner, L., Alonso, J. L., Raper, J. A., & Klagsbrun, M. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.1.233 · Cited by 458
Self-citationGoldman, C. K., Kendall, R. L., Cabrera, G., Soroceanu, L., Heike, Y., Gillespie, G. Y., Siegal, G. P., Mao, X., Bett, A. J., Huckle, W. R., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8795 · Cited by 443
Antiangiogenic Activity of the Cleaved Conformation of the Serpin Antithrombin
O'Reilly, M. S., Pirie-Shepherd, S., Lane, W. S., & Folkman, J. (1999) · Science · doi:10.1126/science.285.5435.1926 · Cited by 432
Kitsukawa, T., Shimono, A., Kawakami, A., Kondoh, H., & Fujisawa, H. (1995) · Development · doi:10.1242/dev.121.12.4309 · Cited by 410
Gluzman-Poltorak, Z., Cohen, T., Herzog, Y., & Neufeld, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909259199 · Cited by 407
Giger, R. J., Urquhart, E. R., Gillespie, S. K. H., Levengood, D. V., Ginty, D. D., & Kolodkin, A. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)80625-x · Cited by 349
Neuropilin-1 Is a Placenta Growth Factor-2 Receptor
Migdal, M., Huppertz, B., Tessler, S., Comforti, A., Shibuya, M., Reich, R., Baumann, H., & Neufeld, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22272 · Cited by 348
Soker, S., Fidder, H., Neufeld, G., & Klagsbrun, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5761 · Cited by 343
Self-citationVascular Endothelial Growth Factors VEGF-B and VEGF-C Are Expressed in Human Tumors
Salven, P., Lymboussaki, A., Heikkilä, P., Jääskela-Saari, H., Enholm, B., Aase, K., von Euler, G., Eriksson, U., Alitalo, K., & Joensuu, H. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65550-2 · Cited by 328
Gagnon, M. L., Bielenberg, D. R., Gechtman, Z., Miao, H.-Q., Takashima, S., Soker, S., & Klagsbrun, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040337597 · Cited by 313
Self-citationMakinen, T., Olofsson, B., Karpanen, T., Hellman, U., Soker, S., Klagsbrun, M., Eriksson, U., & Alitalo, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.21217 · Cited by 310
Self-citationKawakami, A., Kitsukawa, T., Takagi, S., & Fujisawa, H. (1996) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(199601)29:1<1::aid-neu1>3.0.co;2-f · Cited by 291
Klagsbrun, M., & Moses, M. A. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80081-7 · Cited by 237
Self-citationSoker, S., Gollamudi-Payne, S., Fidder, H., Charmahelli, H., & Klagsbrun, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31582 · Cited by 196
Self-citationSondell, M., Lundborg, G., & Kanje, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02056-9 · Cited by 191
Thymosin β15: A novel regulator of tumor cell motility upregulated in metastatic prostate cancer
Bao, L., Loda, M. F., Janmey, P. A., Stewart, R., Anand‐Apte, B., & Zetter, B. R. (1996) · Nature Medicine · doi:10.1038/nm1296-1322 · Cited by 158
Dor, Y., & Keshet, E. (1997) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(97)00091-1 · Cited by 100
Growth cones and the cues that repel them
Kolodkin, A. L. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10057-6 · Cited by 86
Miao, H., Ornitz, D. M., Aĭngorn, E. D., Ben‐Sasson, S. A., & Vlodavsky, I. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119319 · Cited by 82
Self-citationTordjman, R., Ortéga, N., Coulombel, L., Plouët, J., Roméo, P., & Lemarchandel, V. (1999) · Blood · doi:10.1182/blood.v94.7.2301.419k24_2301_2309 · Cited by 67
Cited by
VEGF receptor signalling ? in control of vascular function
Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1911 · Cited by 3,122
Dvorak, H. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.088 · Cited by 1,573
Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis
Kaur, B., Khwaja, F. W., Severson, E. A., Matheny, S. L., Brat, D. J., & Van Meir, E. G. (2005) · Neuro-Oncology · doi:10.1215/s1152851704001115 · Cited by 725
Vascular endothelial growth factor (VEGF) signaling in tumor progression
Roskoski, R. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.01.006 · Cited by 599
Blocking Neuropilin-1 Function Has an Additive Effect with Anti-VEGF to Inhibit Tumor Growth
Pan, Q., Chanthery, Y., Liang, W.-C., Stawicki, S., Mak, J., Rathore, N., Tong, R. K., Kowalski, J., Yee, S. F., Pacheco, G., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.018 · Cited by 532
Metadata
- Authors
- Miao, H., Lee, P., Lin, H., Soker, S., & Klagsbrun, M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2000-12
- Volume
- 14
- Issue
- 15
- Pages
- 2532-2539
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2084228496
- Cited by
- 312
- References
- 47
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.